Unleashing the potential of gene signatures as prognostic and predictive tools: A step closer to personalized medicine in hepatocellular carcinoma (HCC)

Documenti analoghi

• Immune landscape of hepatocellular carcinoma: From dysregulation of the immune responses to the potential immunotherapies
  di: Atieh Pourbagheri‐Sigaroodi, et al.
  Pubblicazione: (2024)
• A Tumor Microenvironment‐Derived CAF‐VEGF Model and Its Application in Biomarker Screening for HCC
  di: Hao Zheng, et al.
  Pubblicazione: (2026)
• Inhibition of the Apelin/APJ Axis Modulates Type 1 Cytotoxic T Cell and Type 2 Cytotoxic T‐Related Immune Responses in an Animal Model of Metastatic Breast Cancer
  di: Tayyebeh Tavakoli, et al.
  Pubblicazione: (2026)
• Reciprocal Interactions Between Apelin and Noncoding RNAs in Cancer Progression
  di: Abdollah Jafarzadeh, et al.
  Pubblicazione: (2024)
• Creation of an in vitro model of GM1 gangliosidosis by CRISPR/Cas9 knocking‐out the GLB1 gene in SH‐SY5Y human neuronal cell line
  di: Kamran Hosseini, et al.
  Pubblicazione: (2024)